Genomic imprinting and Wilms' tumor

Medical and Pediatric Oncology

Volumn 27, Issue 5, 1996, Pages 476-483

  Moulton, Thomas ^a   Chung, Wai Yee ^a   Yuan, Luwa ^a   Hensle, Terrence ^a   Waber, Pamela ^b   Nisen, Perry ^b   Tycko, Benjamin ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

genomic imprinting; H19 gene; Wilms' tumor

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME LOSS; CONTROLLED STUDY; DNA METHYLATION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; NEPHROBLASTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; EPISTASIS, GENETIC; FEMALE; FUNGAL PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; GENOTYPE; GROWTH; HETEROZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MULTIGENE FAMILY; MUSCLE PROTEINS; ONCOGENES; RNA, UNTRANSLATED; SACCHAROMYCES CEREVISIAE PROTEINS; WILMS TUMOR;

EID: 0029818524     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199611)27:5<476::AID-MPO15>3.0.CO;2-8     Document Type: Article

References (42)

1. Tycko B: Genomic imprinting: Mechanism and role in human pathology. Am J Pathol 144:431-443, 1994.
2. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O, Versteeg R: Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: One probably imprinted, another associated with N-myc amplification. Hu Mol Genet 4:535-539, 1995.
3. Scrable H, Cavenne W, Ghavimi F, Lovell M, Morgan K, Sapienza C: A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86:7480-7484, 1989.
4. Schroeder WT, Chao L-Y, Dao DT, Strong LC, Pathak S, Riccardi VM, Lewis WK, Saunders GF: Nonrandom loss of maternal chromosome 11 alleles in Wilms' tumors. Am J Hum Genet 40:413-420, 1987.
5. Williams JC, Brown KW, Mott MG, Maitland NJ: Maternal allele loss in Wilms' tumor. Lancet 1:283-284, 1989.
6. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK: Preferential loss of maternal alleles in sporadic Wilms' tumor. Oncogene 5:1665-1668, 1990.
7. Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A: Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11. Cancer Res 50:3279-3283, 1990.
8. Rainier S, Johnson L, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP: Relaxation of imprinted genes in human cancer. Nature 362:747-749, 1993.
9. Zhang Y, Shields T, Crenshaw T, Hao Y Moulton T, Tycko B: Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms' tumor and potential for somatic allele switching. Am J Hum Genet 53:113-124, 1993.
10. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B: Epigenetic lesions at the H19 locus in Wilms' tumor patients. Nature Genet 7:440-447, 1994.
11. Wilkins RJ: Genomic imprinting and carcinogenesis. Lancet i:329-331, 1988.
12. Guillemot F, Caspary T, Tilghman SM, Copeland NG, Gilbert DJ, Jenkins NA, Anderson DJ, Joyner AL, Rossant J, Nagy A: Genomic imprinting of Mash-2, a mouse gene required for trophoblast development. Nature Genet 9:235-241, 1995.
13. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, Ledbetter DH, Beaudet AL: Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genet 8:52-58, 1994.
14. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls RD, Horsthemke B: Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromsome 15. Nature Genet 9:395-400, 1995.
15. DeChiara TM, Robertson EJ, Efstratiadis A: Paternal imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859, 1991.
16. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedbourg F, Schofield P, Flam F, Ekstrom TJ: IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet 4:94-97, 1993.
17. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C: Parental genomic imprinting of the human IGF2 gene. Nature Genet 4:98-101, 1993.
18. Bartolomei MS, Zemel S, Tilghman SM: Parental imprinting of the mouse H19 gene. Nature 351:153-155, 1991.
19. Zhang Y, Tycko B: Monoallelic expression of the human H19 gene. Nature Genet 1:40-44, 1992.
20. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ: Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317:258-260, 1985.
21. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ: Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 317:260-262, 1985.
22. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B: Tumour-suppressor activity of H19 RNA. Nature 365:764-767, 1993.
23. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekstrom TJ: Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with lack of H19 expression. Development (Camb.) 120:361-368, 1994.
24. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751, 1993.
25. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nature Genet 7:433-439, 1994.
26. Taniguchi T, Sullivan MJ, Osamu O, Reeve A: Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 92:2159-2163, 1995.
27. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM: Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev 5:1663-1673, 1993.
28. Tsang P, Gilles F, Yuan L, Kuo Y-H, Lupu F, Samara G, Moosikasuwan J, Goye A, Zelenetz AD, Selleri L, Tycko B: A novel L23-related gene 40 Kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. Hum Mol Genet 4:1499-1507, 1995.
29. Coppes MJ, Bonetta L, Huang A, Hoban P, Chilton-MacNeill S, Campbell C, Weksberg R, Yeger H, Reeve A, Williams BRG: Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chrom Cancer 5:326-334, 1992.
30. Matsuoka S, Thompson JS, Edwards MC, Barletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP: Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor. p57KIP2, on chromosome 11p15.5 Proc Natl Acad Sci USA 93:3026-3030, 1996.
31. Hatada I, Inazawa J, Abe T, Nakayama M, Yasuhiko K, Jinno Y, Niikawa N, Ohashi H, Yoshimitsu F, Iida K, Yutani C, Takahashi S, Chiba Y, Ohishi S, Mukai, T: Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5:783-788, 1996.
32. Chung W-Y, Yuan L, Feng L, Hensle T, Tycko B: Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Mol Genet 5:1101-1108, 1996.
33. Chao L-Y, Huff V, Tomlinson G, Riccardi VM, Strong LC, Saunders GF: Genetic mosaicism in normal tissues of Wilms' tumor patients. Nature Genet 3:127-131, 1993.
34. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJIII: Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 257:674-678, 1992.
35. Cote GB: Mitotic crossing over and the disruption of genomic imprinting. In Ohlsson R (ed): "Parental Imprinting: Causes and Consequences." Oxford University Press, 1995, pp. 252-263.
36. Haselbacher GK, Irminger J-C, Zapf J, Ziegler WH, Humbel RE: Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci USA 84:1104-1106, 1987.
37. Baccarini P, Fiorentino M, D'Errico A, Mancini AM, Grigioni WF: Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor. Am J Pathol 143:1535-1542, 1993.
38. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T: Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene, 10:1193-1198, 1995.
39. Ariel I, Lustig O, Schneider T, Pizov G, Sappir M, de-Groot N, Hochberg A: The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 45:335-338, 1995.
40. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiatis A, Tilghman SM: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39, 1995.
41. Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJIII, Kaiser LR, Albelda SM: Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 146:344-356, 1995.
42. Krieder JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman DE, Jaenisch R: WT-1 is required for early kidney development. Cell 74:670-691, 1993.